Diabetes risk assessment and glycemic control

JAMA - Journal of the American Medical Association

Volumn 314, Issue 17, 2015, Pages 1861-1862

  Vijan, Sandeep ^a   Fagerlin, Angela ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BLOOD PRESSURE; BODY MASS; CLINICAL CLASSIFICATION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DECISION MAKING; DIABETES EDUCATION; DISEASE ASSOCIATION; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOLOGIST; POINT OF CARE TESTING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINOPATHY; RISK ASSESSMENT; RISK REDUCTION; SELF CARE; SELF REPORT; AMBULATORY CARE; ANALYSIS; DIABETIC RETINOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; MALE; OPHTHALMOLOGY;

BLOOD GLUCOSE; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; OFFICE VISITS; OPHTHALMOLOGY;

EID: 85047288760     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.11518     Document Type: Article

References (9)

1. Aiello LP, Ayala AR, Antoszyk AN, et al. Assessing the effect of personalized diabetes risk assessments during ophthalmologic visits on glycemic control. JAMA Ophthalmol. 2015;133(8): 888-896.
2. Tricco AC, Ivers NM, Grimshaw JM, et al. Effectiveness of quality improvement strategies on the management of diabetes. Lancet. 2012;379 (9833):2252-2261.
3. Norri s SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes. Diabetes Care. 2002;25(7):1159-1171.
4. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control. JAMA. 2006;296(4): 427-440.
5. Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med. 2014;160(8):517-525.
6. Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Helping patients decide. J Natl Cancer Inst. 2011;103(19): 1436-1443.
7. McAlister FA, O'Connor AM,Wells G, Grover SA, Laupacis A. When should hypertension be treated? CMAJ. 2000;163(4):403-408.
8. Vijan S, Sussman JB, Yudkin JS, Hayward RA. Effect of patients' risks and preferences on health gains with plasma glu cose level lowering in type 2 diabetes mellitus. JAMA Intern Med. 2014;174(8): 1227-1234.
9. American Diabetes Association. Standards of medical care in diabetes: 2014. Diabetes Care. 2014; 37(suppl 1):S14-S80.